🇺🇸 FDA
Pipeline program

MYCOHYDRALIN 500 mg, capsule vaginale, FLAGYL 500 mg, comprimé pelliculé, ZITHROMAX 250 mg, comprimé pelliculé, ROCEPHINE 1 g/3,5 ml, poudre et solvant pour solution injectable (IM), GRANUDOXY 100 mg, comprimé pelliculé sécable

AUTOP 2

Phase 3 small_molecule active

Quick answer

MYCOHYDRALIN 500 mg, capsule vaginale, FLAGYL 500 mg, comprimé pelliculé, ZITHROMAX 250 mg, comprimé pelliculé, ROCEPHINE 1 g/3,5 ml, poudre et solvant pour solution injectable (IM), GRANUDOXY 100 mg, comprimé pelliculé sécable for Bacterial vaginosis, High risk preterm birth pregnancy, Vaginal flora abnormalities is a Phase 3 program (small_molecule) at ISTA Pharma Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
ISTA Pharma Limited
Indication
Bacterial vaginosis, High risk preterm birth pregnancy, Vaginal flora abnormalities
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials